Local Growth Fund is Government’s funding pot of at least £2bn a year from 2015/16 to 2020/21.
Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis.
The City Region has a number of funding streams to support economic growth.
Overview of EU funding within the City Region
In 2012 the LEP secured £15m RGF to operate the Business Growth Grant this programme is now closed.
The SIF is the key funding tool for promoting economic growth for Liverpool City Region.